We have identified different members of one family affected by androgen insensitivity syndrome who have deletions of different exons of the X-linked androgen receptor (AR) gene. Two affected (XY) siblings have a deletion of exon E of the AR gene and their affected (XY) aunt has a normal exon E, but a deletion of exons F and G of the same gene. The mother and maternal grandmother of the children both carry the exon E deletion, but not the exon F, G deletion. Both deletions are 5 kb in length and have one breakpoint within a 200-bp region in intron 5; however, they extend in opposite directions. The probability that these two different deletions have arisen at random is extremely low, but the cause of this intriguing phenomenon remains to be found. (J. Clin. Invest. 1993. 91:1123-1128.) Key words: androgen receptor * androgen insensitivity syndrome a mutation * DNA transposable element-site-specific mutagenesis
Introduction
The androgen receptor (AR)' belongs to a superfamily of ligand responsive DNA-binding transcription factors that includes the other steroid receptors, the receptors for thyroid hormone, vitamin D, and retinoic acid, as well as a number of so-called "orphan" receptors, such as the chicken ovalbumin upstream promoter, identified by homology to this family, but for which the ligands remain to be found ( 1, 2) . Members of this superfamily share both DNA sequence and functional homology. The structure of the androgen receptor, illustrated in Fig. 1 , includes the DNA binding and ligand binding domains, which share homology with other members ofthe superfamily, as well as a variable amino-terminal domain, involved in modulation of transcription activation (3, 4) .
The AR gene is located on the X chromosome, at Xq [11] [12] (5) . Mutations in the AR give rise to androgen insensitivity syndrome (AIS), which has a range of clinical presentations. The spectrum includes the complete syndrome, (previously called testicular feminization), in which affected XY individ-uals develop as phenotypic females with female external genitalia, and also includes individuals with ambiguous genitalia, as well as phenotypically normal men who are infertile. A number of reports have identified mutations in the AR gene in patients with complete AIS (for review, see reference 6). These reports include point mutations which define amino acids in the DNA and steroid binding domains absolutely necessary for normal receptor function, premature termination codons, aberrant splicing of mRNA, and one deletion of the entire steroid binding domain ofthe receptor. These studies indicate the heterogeneity of mutations causing AIS.
We have investigated mutations ofthe AR gene in one family with complete AIS. This family has three affected members in two generations, two sisters and their maternal aunt. We have identified a deletion of exon E of the AR gene in the two sisters, and a deletion of exons F and G in their affected aunt.
Methods
Cell culture. Fibroblasts were cultured from pubic skin biopsies and maintained in Eagle's (basal) medium, 10% FCS, and 100 IU/ml penicillin and 100 ,ug/ml streptomycin. Cells were incubated at 37°C in 5% Co2.
Androgen receptor assay. Fibroblasts were assayed in 4X 60-mm dishes, at 80-100% confluency. Cells were assayed using a modification of our previously published method (7), as follows: Cells were incubated at 37°C for 1 h in serum-free DME, washed in ice-cold PBS, then incubated at 37°C for 1 h with 1.0 nM [3H]methyltrienolone (R1881) in the presence and absence of 1,000-fold excess unlabeled R1 881. Cells were then placed on ice and washed five times with ice-cold Tris buffer (20 mM Tris-Cl, 150 mM NaCl, 2 mg/ml BSA, pH 7.4), two times with ice-cold 150 mM NaCl, dried, then solubilized in 0.1 M NaOH. A 500-Al aliquot of the cell lysate was counted and protein content was determined using the Lowry method (8). Specific binding was calculated by subtracting the nonspecific from the total binding. DNA isolation. DNA for PCR was isolated from whole blood and cultured fibroblasts as described (9) . DNA for Southern analysis was isolated using the salting-out lysis method ( 10) followed by phenolchloroform extraction. Polymerase chain reaction. PCR was carried out using primers covering each exon, as illustrated in Fig. 2 (Fig. 3 A) .
Results
Pedigree offamily with AIS. Fig. 4 shows the family, which consists of two affected children, genotypic males but phenotypic females, (III-4 and III-5), their mother, an obligate heterozygote, (II-2), an affected aunt, , the maternal grandmother, (I-1), and four normal female sisters of 11-2 and 11-3.
The affected children and their aunt have identical clinical features of AIS, including intra-abdominal testes, female external genitalia, short vagina, no uterus, and XY karyotype. Androgen receptor binding. Androgen receptor binding was measured in genital skin fibroblasts from the three affected relatives and normal male controls. Genital skin fibroblasts were cultured and specific receptor binding measured using the (Fig. 2 ). Both hemizygous children had no amplification of exon E, but normal amplification of all other exons. Unexpectedly, the hemizygous aunt had no amplification of exons F and G, but normal amplification of all other exons, including exon E. The heterozygous mother and grandmother had normal amplification of all exons, as expected, because both carry one normal AR gene. Fig. 6 shows the PCR products from the family and normal controls for exons D and B (6 A), exons G and E (6 B), and exons C and F (6 C). Each PCR was carried out at least 12 times, using DNA from both blood and cultured fibroblasts collected independently, and results from blood and fibroblasts were identical in all cases.
A PCR fragment from the 5' end of exon E to 3' exon H, spanning the deleted exons, was amplified from the aunt's DNA (Fig. 7 A) . The distance between these primers in the normal genome is -7.5 kb (Fig. 7 B) , and no fragment could grandmother and all normal females in generation II had no amplification of this fragment, indicating that none of them carry this deletion. Sequence analysis confirmed that this 2.5-kb fragment includes all the normal sequence ofexons E and H (data not shown). It was not possible to amplify a PCR product spanning the exon E deletion of the children. The distance from exon D to exon F is -10.9 kb, too large to be amplified even if it contained a large deletion.
The 2.5-kb El /H2 PCR product from the aunt indicates that her mutation is a deletion, and is not caused by a mutation in the hybridization site of one or more of the PCR primers. It also rules out the possibility that the failure ofexons to amplify was caused by translocations that had breakpoints in the middle of these exons. Southern analysis on the aunt's DNA (see next section) also confirms this. Southern analysis also indicates that the children's mutation is also a deletion, and not caused by a translocation or primer hybridization mutation.
Southern analysis localizes deletions. Southern blotting was carried out using exon-specific probes generated by digests of AR cDNA (Fig. 3 A) . For each restriction enzyme used in the Southern blots, at least five separate filters were analyzed. DNA digested with BamHI and hybridized with probe 2 showed a 2.5-kb band in control samples (Fig. 3 B, lane 1) , the same band in the children, who are normal in this region ofthe gene (lanes 2 and 3), but a 3.5-kb band in the aunt, lane 5, indicated with arrow. The mother and grandmother (lanes 4 and 6) had only the 2.5-kb band, but not the 3.5-kb band, meaning that neither of them carry the aunt's mutation.
Sacl digests hybridized with probe 1 (Fig. 3 C) ( 14), we calculate that the size of the exon E deletion in the children, mother, and grandmother is -5 kb. This deletion includes all ofexon E, and has one breakpoint 3' to the HindIII restriction site in intron 4, and extends into intron 5, with the other breakpoint immediately 5' of the Sacl site in this intron (Fig. 8) (Fig. 8) . Thus, in five individuals the deleted region is upstream from the common breakpoint, while in another individual, the deletion is downstream. Exons E, F, and G all code for the steroid binding domain of the receptor.
The deletion ofexons E and F, G in the affected individuals is sufficient to explain their receptor negative AIS. Both deletions would alter the reading frame of the downstream exons, resulting in the production ofabnormal receptors, lacking vital parts of the steroid binding domain. The inability of the receptor to bind ligand would thus render the target tissues unresponsive to androgens. It is extremely likely that the described AR gene deletions are the cause ofthe AIS in these individuals.
The significant feature of this family is the fact that there are two different mutations carried by different affected individuals. Both mutations are deletions, are approximately the same size, and have one breakpoint immediately 5' to the Sacd restriction site in intron 5, but they extend in opposite directions in the gene (Fig. 8) ( 15) , and in hemophilia B associated with an Alu repeat ( 16) . It has been shown to be mediated by eukaryotic DNA topoisomerase II in vitro ( 17) , and hotspots for illegitimate recombination have been identified in mouse cells, associated with DNA topoisomerase I and II cleavage sequences ( 18, 19 (22) and maize (23, 24) to Drosophila (25, 26) and mice (27) , and deletions have been identified caused by the excision of adjacent transposable elements (23) . Transposon-like sequences have been found in the human genome (28, 29) , and the first case of a functional element inserted in the Factor VIII gene causing hemophilia A has recently been reported (30, 31 Laboratories for Reproductive Biology, University of North Carolina (Chapel Hill, NC). We thank Dr. Fiona Joske for her help in collection of patient samples. We also thank the Royal Children's Hospital Congenital Adrenal Hyperplasia Support Group for the donation ofmoney to purchase the Hybaid Thermal Reactor.
